Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 7 January 2019
Accepted: 15 January 2019
First Online: 23 January 2019
Conflict of interest
: R. Bartsch declares the following relationships: advisory role (Astra-Zeneca, Celgene, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Roche), lecture honoraria (Accord, Astra-Zeneca, BMS, Celgene, Eli-Lilly, Novartis, Pfizer, Roche) and research support (Novartis, Roche). E. Bergen and A. Galid declare that they have no competing interests.